VOR- Vor Biopharma Inc.

Name: Vor Biopharma Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Vor Biopharma Inc. (VOR) has 17 insiders with recent SEC Form 4 filings, including 5 buys and 10 sells. VOR is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Kress Jean-Paul	4.16M	$66.97M	-
10%	Ra Capital Management, L.P.	2.40M	$38.63M	-1,669,542
10%	Reprogrammed Interchange LLC	1.17M	$18.76M	-
Other	Zuraw Qing Che	218.7K	$3.52M	-
Dir	Reed Sarah Burgess	60.0K	$964.8K	-

Activity

Buys and sells only

Transactions

10 filings · page 3

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Aug 26, 2025	Reprogrammed Interchange LLC51	10% Owner	Sell	671,536	$2.10	$1,411,082.89	-0.9%	-79.9%	-
Feb 13, 2025	Attar Eyal C.85	Chief Medical Officer	Sell	2,227	$1.42	$3,162.34	-1.7%	-87.1%	-52.0%
Feb 10, 2025	Attar Eyal C.85	Chief Medical Officer	Sell	2,554	$1.37	$3,498.98	-1.9%	-87.5%	-49.7%
Dec 30, 2024	Reprogrammed Interchange LLC51	10% Owner	Buy	38,974,101	$0.00	-	New	-39.7%	-47.4%
Dec 27, 2024	Attar Eyal C.85	Chief Medical Officer	Sell	10,334	$1.25	$12,917.50	-11.3%	-39.7%	-42.0%
Jun 3, 2024	Attar Eyal C.85	Chief Medical Officer	Sell	14,645	$1.39	$20,356.55	-13.2%	-41.7%	-84.5%
Nov 16, 2021	Parmar Kush67	Director, 10% Owner	Sell	330,706	$15.30	$5,059,801.80	-4.9%	-52.4%	-74.0%
Nov 16, 2021	5am Ventures Vi, L.P.	10% Owner	Sell	477,740	$15.30	$7,309,422.00	-4.9%	-52.4%	-74.0%
Feb 9, 2021	5am Ventures Vi, L.P.	10% Owner	Buy	555,555	$18.00	$9,999,990.00	+9.1%	-	-
Feb 9, 2021	Ra Capital Management, L.P.52	Director, 10% Owner	Buy	2,979,566	$18.00	$53,632,188.00	+41.7%	-	-

← PrevPage 3Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC